Biomarker & Bioanalytical Strategy Lead, RNA Therapeutics

Borealis Biosciences, Inc.

Vancouver

In loco

CAD 288.000 - 336.000

Tempo pieno

14 giorni+

Aumenta le possibilità di ricevere una risposta da questo datore di lavoro

Il tuo curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che sta cercando.

Supera i filtri ATS

Vantaggi offerti da questo lavoro

Annual bonus
Equity program
RRSP matching
Paid time-off

Descrizione del lavoro

Borealis Biosciences, Inc. is seeking a Biomarker & Bioanalytical Development Lead to own the bioanalytical and biomarker strategy across the RNA therapeutics portfolio.

This senior scientist will design, build, and oversee assays measuring drug exposure, target engagement, pharmacodynamic response, and safety to support IND-enabling nonclinical and early clinical development. The role focuses on preparing for a Phase 1/2 trial, including development and transfer of regulated PK assays,

Competenze

  • PhD in pharmacology, analytical chemistry, molecular biology, immunology, biochemistry, or related discipline with 10+ years of relevant biotech/pharma experience.
  • BS/MS with additional equivalent experience may be considered.
  • Deep hands-on expertise in bioanalytical and biomarker assay development.
  • Experience in regulated environments (GLP, GCLP, CLIA) and ICH M10 guidance.
  • Proven success leading outsourced bioanalytical and biomarker work, including CRO selection and method transfer.
  • Strong data interpretation and scientific judgment; cross-functional collaboration.

Mansioni

  • Define and own the bioanalytical strategy for Borealis RNA programs from discovery through IND-enabling studies.
  • Lead development of fit-for-purpose assays to quantify oligonucleotide therapeutics and metabolites in plasma, urine, and tissues.
  • Establish ADA strategy and assays where required by modality or regulatory expectations.
  • Ensure method validation and sample analysis meet regulatory expectations (ICH M10, GLP/GCLP/CLIA).
  • Partner with DMPK, Toxicology, Pharmacology, and Chemistry to integrate bioanalytical data into PK/PD modeling and program decisions.
  • Lead CRO/biomarker outsourcing, including selection, transfer, and oversight of labs and reports.
  • Build and mentor the Biomarker & Bioanalytical team; foster ownership and scientific rigor.
  • Promote Borealis values and a culture of collaboration, transparency, and urgency.

Conoscenze

Bioanalytical assays
Biomarker assays
GLP/GCLP/CLIA
CRO management
IND submissions
Leadership
Cross-functional

Formazione

PhD or equivalent
BS/MS + equivalent experience

Strumenti

LC-MS/MS
LC-HRMS
Stem-loop RT-qPCR
Hybridization ELISA

Descrizione del lavoro

Borealis Biosciences, Inc. is seeking a Biomarker & Bioanalytical Development Lead to own the bioanalytical and biomarker strategy across the RNA therapeutics portfolio.

This senior scientist will design, build, and oversee assays measuring drug exposure, target engagement, pharmacodynamic response, and safety to support IND-enabling nonclinical and early clinical development. The role focuses on preparing for a Phase 1/2 trial, including development and transfer of regulated PK assays,

Ottieni la revisione del curriculum gratis e riservata.

o trascina qui il file.

Similar jobs

Offerte di lavoro simili che vale la pena confrontare

Biomarker & Bioanalytical Strategy Lead
Biomarker & Bioanalytical Strategy Lead

Borealis-Biosciences,-Inc. • Vancouver

In loco
CAD 202.000 - 236.000
Annual bonus program
Equity program
Paid time off
+4
Biomarker & Bioanalytical Development Lead (Director / Senior Director)
Biomarker & Bioanalytical Development Lead (Director / Senior Director)

Borealis-Biosciences,-Inc. • Vancouver

In loco
CAD 202.000 - 236.000
Annual bonus program
Equity program
Paid time off
+4
Biomarker & Bioanalytical Development Lead (Director / Senior Director)
Biomarker & Bioanalytical Development Lead (Director / Senior Director)

Borealis Biosciences, Inc. • Vancouver

In loco
CAD 288.000 - 336.000
Annual bonus
Equity program
RRSP matching
+1
Head of Clinical Operations (Sr. Director / Executive Director)
Head of Clinical Operations (Sr. Director / Executive Director)

Borealis Biosciences, Inc. • Vancouver

Ibrido
CAD 313.000 - 389.000
Annual bonus
Equity program
Paid time off
+2
Head of Clinical Operations (Sr. Director / Executive Director)
Head of Clinical Operations (Sr. Director / Executive Director)

Borealis-Biosciences,-Inc. • Vancouver

Ibrido
CAD 313.000 - 389.000
Immigration support program
Relocation benefits
Travel to Vancouver office
+4
Neurology & Neuro-Rare Therapeutic Lead | Strategic Growth
Neurology & Neuro-Rare Therapeutic Lead | Strategic Growth

BioScript Solutions • Oakville

Ibrido
CAD 120.000 - 160.000
Flexible remote work options
Growth opportunities
Vibrant culture
+1
Cardiometabolic MSL – Montreal: RNAi & Metabolic Therapies
Cardiometabolic MSL – Montreal: RNAi & Metabolic Therapies

Arrowhead Pharmaceuticals, Inc. • Montreal

Ibrido
CAD 90.000 - 130.000
Medical Science Liaison
Medical Science Liaison

Arrowhead Pharmaceuticals, Inc. • Montreal

In loco
CAD 90.000 - 130.000
Bioassay NPI Supervisor: Lead Cell-Based Potency Testing
Bioassay NPI Supervisor: Lead Cell-Based Potency Testing

AbbVie • Westport

In loco
CAD 90.000 - 120.000
Next-Gen RNA Therapeutics Researcher
Next-Gen RNA Therapeutics Researcher

University of British Columbia • Vancouver

In loco
CAD 69.000 - 93.000